General Information of the Protein
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000059 , HuT 78
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Bromodomain-containing protein 2 (BRD2) )
| Target Type | Clinical trial Target | ||||
|---|---|---|---|---|---|
| Disease | 2 Target-related Diseases | 2 | |||
| 1 | Prostate cancer [ICD-11: 2C82.0] | ||||
| 2 | Acute myeloid leukaemia [ICD-11: 2A60] | ||||
| Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
| 1 | ABBV-744 | Phase 1 | |||
| 2 | OTX-015 | Phase 1/2 | |||
Target 2 ( HUMAN bromodomain-containing protein 2 (BRD2) )
| Target Type | Unknown Type Target | ||||
|---|---|---|---|---|---|
| Disease | 1 Target-related Disease | 1 | |||
| 1 | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | ||||
| Investigative Drug(s) | 2 Investigative Drugs | 2 | |||
| 1 | ABBV-744 | Investigative | |||
| 2 | JQ1 | Investigative | |||